Monitoring advanced glaucoma with AI to track central vision
Official title: Monitoring of Glaucoma Patients in Advanced Disease
Funded at University of California, San Diego · NIH-11418939 · Data updated 2026-11-12
A study at UC San Diego uses computer-based AI tools to watch how severe glaucoma changes the central vision and macula over time so doctors can tailor care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Diego NIH-funded |
| Lab location | 1 site (La Jolla, United States) |
| Project start | September 1, 2022 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $515,556 |
| NIH project number | 5R01EY034148-05 |
| Project ID | NIH-11418939 on NIH RePORTER |
Who could benefit from this research
✓Could help
Individuals with advanced open-angle glaucoma and measurable central visual field function.
✕Less likely to help
Patients with less advanced glaucoma or other eye diseases not meeting the advanced criteria may not benefit from this approach.
What this research studies
People with very advanced glaucoma often retain only a tiny central vision, making monitoring difficult. This project follows patients over time to map how central vision and macular structure change and to build AI-powered models that can detect and predict progression. It will combine central visual field data with new macular imaging to improve prediction of worsening vision. The goal is to give clinicians better guidance for when to adjust treatments in advanced disease.
Why it matters
Potential benefit: If successful, patients with advanced glaucoma could receive more accurate monitoring and timely treatment changes to protect remaining vision.
How similar studies have gone: Previous work suggests AI can help detect glaucoma progression, but this study targets the challenging advanced stage with central vision focus.
Where this research is happening
-
University of California, San Diego
La Jolla, United States Active
Researchers
- Principal investigator: Moghimi Araghi, Sasan — University of California, San Diego
- Study coordinator: Moghimi Araghi, Sasan
Related research
Other NIH-funded projects on the same topics.
-
IOP and CSF Pressure in Glaucoma Risk
This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.
-
Comparing tube positions in glaucoma implants to protect corneal cells
This trial compares two tube placements for glaucoma drainage implants to see which better protects corneal cells and controls eye pressure in people with uncontrolled glaucoma.
-
Automated topographic test for glaucoma detection and progression
A new automated method uses topographic structure-function mapping to help diagnose glaucoma earlier and track its progression in patients.
-
Using AI on eye scans and genes to predict glaucoma risk
This project uses artificial intelligence on eye scans, vision tests, and genetic information to find people most likely to develop or have worsening glaucoma.
-
AI-based glaucoma screening in community health centers
A new, easy-to-use AI screening approach will be tested in federally funded health centers to help identify people at risk for glaucoma, especially in communities with higher risk.
-
Understanding how glaucoma genes control eye cell function
A long-term research project will study how genetic factors affect eye cells in adults with glaucoma to uncover new ideas for protecting vision.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.